Romania - Cluj-Napoca: Medical analysis services

Release

ID
ocds-pyfy63:2021-235998:2023-433631
Date
2023-07-18
Language
RO
Tags
award

Release in JSON

Tender

Title
Romania - Cluj-Napoca: Medical analysis services
Award criteria
priceOnly
Award criteria details
Lowest price

Award criteria for item 1:
- Price

Award criteria for item 2:
- Price

Award criteria for item 3:
- Price

Award criteria for item 4:
- Price

Award criteria for item 5:
- Price

Award criteria for item 6:
- Price

Award criteria for item 7:
- Price

Award criteria for item 8:
- Price
Main procurement category
services
Procurement method
open
Procurement method details
Open procedure
Tender period
2023-07-18 - ?

Tender item

ID
ocds-pyfy63:2021-235998:obj:1
Classification
CPV / 85148000
Description
Nr. Crt.. Denumire analiza Contract subsecvent(minime) /Contract subsecvent(maxime) /Cantitati/AC minime(24 luni) / /Cantitati/AC maxime(24 luni)1. 1,25 dihidroxi vitamina D 1 /10 /2 /203. 17-hidroxiprogesteron 50 /100 /100 /2004. Adiponectina 1 /10 /2 /205. Aldosteron 15 /30 /30 /606. Androstendion 15 /30 /30 /607. Homocisteină 1 /10 /2 /208. Hormon anti-Mullerian 1 /10 /2 /209. Inhibina B 1 /10 /2 /2010. Leptina 15 /30 /30 /6011. Testosteron liber 1 /10 /2 /2012. Tiroglobulina 15 /30 /30 /6013. Trioiodotironina serica totala (T3 total) 1 /10 /2 /2014. Tiroxina serica totala (T4 total) 1 /10 /2 /2015. Cortizol liber urinar/24h 1 /15 /10 /30Valoarea celui mai mare contract subsecvent este de 32500,00lei fara TVA.

Tender item

ID
ocds-pyfy63:2021-235998:obj:2
Classification
CPV / 85148000
Description
Nr. Crt. Denumire analiza Cantitati estimate contract subsecvent(min / max) Cantitati estimate Acord cadru(min. / max)1. Acid folic (vitamina B9) 10 /20 /20 / /402. Acid vanilmandelic 1 /10 /2 / /203. Acizi biliari in ser 1 /10 /2 / /204. Aminoacizi in plasma 50 /75 /100 / /1505. Aminoacizi in urina 1 /10 /2 / /206. Apolipoproteina A1 1 /10 /2 / /207. C1 Inhibitor esterază (activitate) 1 /10 /2 / /208. Complement C1 inhibitor 1 /10 /2 / /209. Catecolamine urinare 1 /10 /2 / /2010. Ceruloplasmina 25 /50 /50 / /10011. CK izoenzime 1 /10 /2 / /2012. Crioglobuline 1 /10 /2 / /2013. Cu seric 1 /10 /30 / /6014. Cu urinar 15 /30 /30 / /6015. Electroforeza Hb 15 /30 /50 / /10016. IgD (imunoglobulina D) 25 /50 /10 / /3017. IGF-binding protein 3 5 /15 /2 / /2018. Interleukina 10 1 /10 /2 / /2019. Iod seric 1 /10 /2 / /2020. Metanefrine libere plasmatice 1 /10 /10 / /3021. Quantiferon TBC test 5 /15 /100 / /20022. Renina plasmatica 50 /100 /50 / /10023. TNF α 25 /50 /10 / /3024. Vitamina B12 5 /15 /30 / /6025. Acilcarnitina 15 /30 /50 / /10026. Carnitina libera in plasma 25 /50 /50 / /10027. Acizi organici serici 25 /50 /50 / /10028. Acizi organici urinari 25 /50 /50 / /10029. NSE (neuron-specific enolase) 25 /50 /50 / /10030. Cistatina 25 /50 /50 / /10031. Calcitonina 25 /50 /50 / /10032. Homocisteina 5 /15 /10 / /30Valoarea celui mai mare contract subsecvent este de 122195,00lei fara TVA.

Tender item

ID
ocds-pyfy63:2021-235998:obj:3
Classification
CPV / 85148000
Description
Nr. Crt.. Denumire analiza Contract subsecvent(maxime) /Pret/analiza /Cantitati/AC maxime(24 luni) / /Contract subsecvent(minime)1. Amiotrofie spinala (deletie exon7 si 8) 1 /5 /2 /102. Analiza genetica pentru distrofie musculara (deletii/duplicatii) 1 /5 /2 /103. Cariotip maduva osoasa 15 /30 /30 /604. Cariotip sange perific 1 /5 /2 /105. Mutatia factorului XIII(G102T) - risc trombofilie 1 /5 /2 /106. Mutatii genetice pentru sindrom X-fragil 1 /5 /2 /107. Profil genetic al riscului de trombofilie 1 /5 /2 /108. Sindrom Gilbert-testare genetica (promotor UGT1A1) 1 /5 /2 /109. Mutatiile genei MTHFR 1 /5 /2 /1010. Pachet pentru evaluarea LAM (FLT3 si NPM1) 5 /10 /10 /2011. Pachet pentru evaluarea fuziunilor in LAL 10 /20 /20 /4012. Mutatia JAK2 1 /5 /2 /1013. Sindrom MELAS 1 /5 /2 /1014. Sindrom MERRF 1 /5 /2 /1015. Sindrom NARP 1 /5 /2 /1016. Genotipare TPMT 1 /5 /2 /1017. Fibroza chistica (Gena CFTR) 5 /10 /10 /20Valoarea celui mai mare contract subsecvent este de 152010,00lei fara TVA.

Tender item

ID
ocds-pyfy63:2021-235998:obj:4
Classification
CPV / 85148000
Description
Nr. Crt.. Denumire analiza Contract subsecvent(minime) /Contract subsecvent(maxime) /Cantitati/AC minime(24 luni) / /Cantitati/AC maxime(24 luni)1. Dozare Carbamazepina 10 /20 /20 /402. Dozare nivel seric acid valproic 1 /10 /2 /203. Dozare nivel seric topiramat 1 /10 /2 /204. Dozare nivel seric levetiracetam 5 /15 /10 /305. Dozare nivel seric clonazepam 1 /10 /2 /206. Dozare nivel seric fenobarbital 1 /10 /2 /20Valoarea celui mai mare contract subsecvent este de 10515,00lei fara TVA.

Tender item

ID
ocds-pyfy63:2021-235998:obj:5
Classification
CPV / 85148000
Description
Nr. Crt.. Denumire analiza Contract subsecvent(minime) /Contract subsecvent(maxime) /Cantitati/AC minime(24 luni) / /Cantitati/AC maxime(24 luni)1. Ac. anticardiolipina IgM 15 /30 /30 /602. Ac. anticardiolipina IgG 5 /15 /10 /303. Anticoagulant lupic 15 /30 /30 /604. Antitrombina III (activitate) 10 /20 /20 /405. Antitrombina III (concentratie) 1 /10 /2 /206. Factor IX (activitate) 1 /10 /2 /207. Factor VIII (activitate) 1 /10 /2 /208. Factor V (activitate) 1 /10 /2 /209. Factor VII (activitate) 1 /10 /2 /2010. Factor von Willenbrand (activitate) 5 /15 /10 /3011. Factor von Willenbrand (antigen) 5 /15 /10 /3012. Proteina S libera (antigen) 1 /10 /2 /2013. Proteina S (activitate) 10 /20 /20 /4014. Proteina C (activitate) 10 /20 /20 /40Valoarea celui mai mare contract subsecvent este de 19605,00lei fara TVA.

Tender item

ID
ocds-pyfy63:2021-235998:obj:6
Classification
CPV / 85148000
Description
Nr. Crt.. Denumire analiza Contract subsecvent(minime) /Contract subsecvent(maxime) /Cantitati/AC minime(24 luni) / /Cantitati/AC maxime(24 luni)1. Ac.anti beta2 glicoproteina I IgM 10/20/ 20/402. Ac.anti beta2 glicoproteina I IgG 10/20/ 20/403. Ac anti peptid cyclic citrulinat (CCP) 1/10 /2/204. Ac antireceptor TSH 15/30 /30/605. Ac antitiroglobulină 25 /50 /50/1006. Ac. anti glutamat -decarboxilaza GAD II 30/60 /60/1207. Ac. anti IA2 15/30 /30/608. Ac. anti insulin-IgG 5/15 /10/309. Ac anti ICA (insule pancreatice) 30/15 /30/60Valoarea celui mai mare contract subsecvent este de 22360,00lei fara TVA.

Tender item

ID
ocds-pyfy63:2021-235998:obj:7
Classification
CPV / 85148000
Description
Nr. Crt.. Denumire analiza Contract subsecvent(minime) /Contract subsecvent(maxime) /Cantitati/AC minime(24 luni) / /Cantitati/AC maxime(24 luni)1. ADN CMV 25 /50 /50 /1002. ADN HBV (cantitativ) 10 /20 /20 /403. ARN VHC (cantitativ) 1 /10 /2 /204. AND Epstein-Barr-Virus (EBV) in sange(cantitativ) 15 /30 /30 /605. ADN virus Polyoma - BK (PCR) cantitativ 5 /15 /10 /306. HLAB27 10 /20 /20 /40Valoarea celui mai mare contract subsecvent este de 48250,00lei fara TVA.

Tender item

ID
ocds-pyfy63:2021-235998:obj:8
Classification
CPV / 85148000
Description
Nr. Crt.. Denumire analiza Contract subsecvent(minime) /Contract subsecvent(maxime) /Cantitati/AC minime(24 luni) / /Cantitati/AC maxime(24 luni)1. Ac anti Adenovirus-IgM 1 /10 /2 /202. Ac anti Bartonella henselae-IgM 10 /20 /20 /403. Ac anti Bordetella pertussis Ig A 1 /10 /2 /204. Ac anti Borrelia burgdorferi Ig M 50 /75 /100 /1505. Ac anti Borrelia burgdorferi IgG 25 /50 /50 /1006. Ac anti Echinococcus granulosus Ig G 1 /10 /2 /207. Ac anti enterovirusuri (IgG, IgA, IgM) 1 /10 /2 /208. Ac anti toxocara canis IgG 25 /50 /50 /1009. Ac anti virus rubeolic Ig M 25 /50 /50 /10010. Ac anti virus rubeolic Ig G 10 /20 /20 /4011. Ac anti virus rujeolic IgM 25 /50 /50 /10012. Ac anti virus rujeolic IgG 5 /15 /10 /3013. Ac Chlamidia trachomatis IgA 1 /10 /2 /2014. Ac. anti virus Coxsackie B IgM 10 /20 /20 /40Valoarea celui mai mare contract subsecvent este de 29815,00lei fara TVA.

Award

ID
ocds-pyfy63:2021-235998:award:0
Title
Contract subsecvent
Date
2023-02-01
Status
active
Suppliers
GENETIC CENTER

Award

ID
ocds-pyfy63:2021-235998:award:1
Title
Contract subsecvent
Date
2021-07-14
Status
active

Award

ID
ocds-pyfy63:2021-235998:award:2
Title
Contract subsecvent
Date
2022-10-01
Status
active
Suppliers
GENETIC CENTER

Award

ID
ocds-pyfy63:2021-235998:award:3
Title
Contract subsecvent
Date
2023-01-03
Status
active
Suppliers
GENETIC CENTER

Award

ID
ocds-pyfy63:2021-235998:award:4
Title
Contract subsecvent
Date
2023-04-12
Status
active
Suppliers
GENETIC CENTER

Award

ID
ocds-pyfy63:2021-235998:award:5
Title
Contract subsecvent
Date
2023-06-15
Status
active
Suppliers
GENETIC CENTER

Award

ID
ocds-pyfy63:2021-235998:award:6
Title
Contract subsecvent
Date
2021-09-24
Status
active

Award

ID
ocds-pyfy63:2021-235998:award:7
Title
Contract subsecvent
Date
2022-02-01
Status
active
Suppliers
GENETIC CENTER

Award

ID
ocds-pyfy63:2021-235998:award:8
Title
Contract subsecvent
Date
2022-01-04
Status
active

Award

ID
ocds-pyfy63:2021-235998:award:9
Title
Contract subsecvent
Date
2022-03-01
Status
active

Award

ID
ocds-pyfy63:2021-235998:award:10
Title
Contract subsecvent
Date
2022-07-01
Status
active

Award

ID
ocds-pyfy63:2021-235998:award:11
Title
Contract subsecvent
Date
2022-03-01
Status
active
Suppliers
GENETIC CENTER

Award

ID
ocds-pyfy63:2021-235998:award:12
Title
Contract subsecvent
Date
2022-01-04
Status
active
Suppliers
GENETIC CENTER

Award

ID
ocds-pyfy63:2021-235998:award:13
Title
Contract subsecvent
Date
2022-07-01
Status
active
Suppliers
GENETIC CENTER

Award

ID
ocds-pyfy63:2021-235998:award:14
Title
Acord cadru
Date
2021-07-08
Status
active
Suppliers
GENETIC CENTER

Award

ID
ocds-pyfy63:2021-235998:award:15
Title
Acord cadru
Date
2021-07-08
Status
active

Award

ID
ocds-pyfy63:2021-235998:award:16
Title
Contract subsecvent
Date
2022-04-01
Status
active

Award

ID
ocds-pyfy63:2021-235998:award:17
Title
Contract subsecvent
Date
2022-04-01
Status
active
Suppliers
GENETIC CENTER

Award

ID
ocds-pyfy63:2021-235998:award:18
Title
Contract subsecvent
Date
2023-01-03
Status
active

Award

ID
ocds-pyfy63:2021-235998:award:19
Title
Contract subsecvent
Date
2022-10-01
Status
active

Award

ID
ocds-pyfy63:2021-235998:award:20
Title
Contract subsecvent
Date
2023-05-05
Status
active

Award

ID
ocds-pyfy63:2021-235998:award:21
Title
Contract subsecvent
Date
2021-07-14
Status
active
Suppliers
GENETIC CENTER

Award

ID
ocds-pyfy63:2021-235998:award:22
Title
Contract subsecvent
Date
2022-03-09
Status
active

Award

ID
ocds-pyfy63:2021-235998:award:23
Title
Contract subsecvent
Date
2023-02-01
Status
active

Award

ID
ocds-pyfy63:2021-235998:award:24
Title
Contract subsecvent
Date
2023-04-05
Status
active

Award

ID
ocds-pyfy63:2021-235998:award:25
Title
Contract subsecvent
Date
2023-06-16
Status
active

Award

ID
ocds-pyfy63:2021-235998:award:26
Title
Contract subsecvent
Date
2023-05-05
Status
active
Suppliers
GENETIC CENTER

Award

ID
ocds-pyfy63:2021-235998:award:27
Title
Contract subsecvent
Date
2022-02-01
Status
active

Award

ID
ocds-pyfy63:2021-235998:award:28
Title
Contract subsecvent
Date
2021-09-29
Status
active
Suppliers
GENETIC CENTER

Parties

Roles
buyer
Organization name
Spitalul Clinic de Urgenta pentru Copii Cluj-Napoca
Street address
Strada: Moţilor, nr. 68
Locality
Cluj-Napoca
Postal code
400370
Country
RO
Contact name
Stanciu Ioan
E-mail
achizitii@spitcocluj.ro
Phone
+40 0264593518
Fax
+40 0264593518
Website
www.e-licitatie.ro

Organization data Organization in JSON

Roles
supplier
tenderer
Organization name
GENETIC CENTER
Street address
Strada Observatorului, Nr. 109
Locality
Cluj-Napoca
Postal code
400363
Country
RO
E-mail
rares.prodan@geneticcenter.ro
Phone
+40 0729931700
Website
www.reginamaria.ro

Organization data Organization in JSON

Roles
supplier
tenderer
Organization name
LABORATOARELE BIOCLINICA S.R.L
Street address
Strada B-dul Cetatii, Nr. 53B
Locality
Timisoara
Postal code
300358
Country
RO
E-mail
marius.pop@bioclinica.ro
Phone
+40 799401406
Fax
+40 0256227028
Website
www.bioclinica.ro

Organization data Organization in JSON